News Reduction of share capital Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Continue Reading Previous Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss Related Stories News Exterro Launches Industry’s First Autonomous AI Engine to Eliminate Up to 95% of manual Subpoena Work and Reclaim 7,500 Enterprise Hours News Exterro Unveils ARMOUR: A Vision for Autonomous Risk Management That Redefines the Future of Enterprise Legal and Data Governance News MagtiCom Selects Mavenir for Next-Generation Small Cell Technology Roll-Out Across Georgia News CleverTap and Rabbit Rewards win Silver at Thailand MarTech Awards 2026 for real-time, agentic customer engagement News Gold Peak completes a HK$675 million Green and Sustainability Linked Term Loan Facility News Hidden Champion of Five-axis Machine Tools Breaks Foreign Monopoly!
